Belite Bio Inc ADR (BLTE) had the highest return between June 5, 2022 and June 30, 2022 by a mid-cap US stock, returning 105.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Belite Bio Inc ADR (BLTE) | 6/5/2022 - 6/30/2022 | 105.41% |
New Oriental Education & Technology (EDU) | 6/5/2022 - 6/30/2022 | 48.94% |
Nuvalent (NUVL) | 6/5/2022 - 6/30/2022 | 46.75% |
Miniso Group Holding (MNSO) | 6/5/2022 - 6/30/2022 | 46.46% |
Axsome Therapeutics (AXSM) | 6/5/2022 - 6/30/2022 | 46.02% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/5/2022 - 6/30/2022 | 45.81% |
Arcellx (ACLX) | 6/5/2022 - 6/30/2022 | 35.94% |
PTC Therapeutics (PTCT) | 6/5/2022 - 6/30/2022 | 33.58% |
Garrett Motion (GTX) | 6/5/2022 - 6/30/2022 | 30.57% |
Amicus Therapeutics (FOLD) | 6/5/2022 - 6/30/2022 | 30.18% |
BridgeBio Pharma (BBIO) | 6/5/2022 - 6/30/2022 | 28.61% |
Disc Medicine (IRON) | 6/5/2022 - 6/30/2022 | 28.03% |
HUTCHMED DRC (HCM) | 6/5/2022 - 6/30/2022 | 26.4% |
Ocular Therapeutix (OCUL) | 6/5/2022 - 6/30/2022 | 26.02% |
Gitlab (GTLB) | 6/5/2022 - 6/30/2022 | 25.78% |
Kymera Therapeutics (KYMR) | 6/5/2022 - 6/30/2022 | 24.94% |
Celcuity LLC (CELC) | 6/5/2022 - 6/30/2022 | 24.66% |
Viking Therapeutics (VKTX) | 6/5/2022 - 6/30/2022 | 22.98% |
Ollie's Bargain Outlet Hldg (OLLI) | 6/5/2022 - 6/30/2022 | 21.36% |
Kiniksa Pharmaceuticals (KNSA) | 6/5/2022 - 6/30/2022 | 19.33% |
Denali Therapeutics (DNLI) | 6/5/2022 - 6/30/2022 | 19.15% |
Privia Health (PRVA) | 6/5/2022 - 6/30/2022 | 18.42% |
Legend Biotech (LEGN) | 6/5/2022 - 6/30/2022 | 17.1% |
Impinj (PI) | 6/5/2022 - 6/30/2022 | 16.41% |
ELF Beauty (ELF) | 6/5/2022 - 6/30/2022 | 15.6% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
